Previous Close | 4.3000 |
Open | 4.3000 |
Bid | 2.8500 |
Ask | 3.5000 |
Strike | 5.00 |
Expire Date | 2024-12-20 |
Day's Range | 4.3000 - 4.3000 |
Contract Range | N/A |
Volume | |
Open Interest | 73 |
Accolade, Inc. (Nasdaq: ACCD) announced today that Noom has joined Accolade's Trusted Partner Ecosystem to provide customers with a comprehensive solution for weight loss and metabolic health, including support for GLP-1s and other anti-obesity medications. In addition to the standard integrated features that drive appropriate Trusted Partner utilization, Noom's clinical obesity management solution, Noom Med, will be powered by Accolade physicians extensively trained in weight loss protocols and
Accolade, Inc. (NASDAQ:ACCD) Q4 2024 Earnings Call Transcript April 25, 2024 Accolade, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.11. Accolade, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and thank you for standing by. […]
In this article, we will take a detailed look at the 10 Cathie Wood Stocks Insiders are Selling. For a quick overview of such stocks, read our article 5 Cathie Wood Stocks Insiders are Selling. There was a time Cathie Wood talked about her famous “five-year investment horizon” with confidence, giving investors hope that the high-growth, cash-burning companies she […]